Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3040491	pf-ace	u/l (u/l)	254	280	3.57%
3040491	pf-ace	— (—)	125	130	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Pleural effusion

168

71.88

310.62

1.2

1.1

17.35

15.23

u/l

0.27

126

Other diseases of pleura

220

27.73

297.58

1.2

1.1

18.07

19.58

u/l

0.28

163

Other pleural conditions

67.21

168.05

1.1

20.13

17.00

u/l

—

Lung cancer and mesothelioma

31.94

71.19

1.2

1.1

21.75

11.28

u/l

—

Heart failure,strict

111

105

7.65

68.06

1.2

1.1

16.33

23.48

u/l

1.99

Heart failure, not strict

131

142

6.38

67.52

1.2

1.0

18.49

24.68

u/l

1.80

Heart failure, strict

117

137

6.17

59.73

1.2

1.1

15.61

22.07

u/l

2.17

All-cause Heart Failure

113

136

6.01

56.34

1.2

1.1

15.78

22.27

u/l

2.16

Other pulmonary diagnosis

8.93

49.40

1.1

1.0

21.58

23.27

u/l

0.14

Heart failure and antihypertensive medication

12.64

48.95

1.2

1.1

17.39

22.91

u/l

0.74

Excluding asthma or asthma-COPD overlap

8.83

48.52

1.1

1.0

22.21

23.27

u/l

0.08

COPD differential diagnosis

8.90

48.22

1.1

1.0

22.34

23.27

u/l

0.07

ILD differential diagnosis

8.90

48.22

1.1

1.0

22.34

23.27

u/l

0.07

Other bacterial diseases

130

210

4.29

44.59

1.1

18.58

22.21

u/l

0.99

132

Renal failure

162

5.21

43.75

1.1

21.41

17.17

u/l

0.86

106

All pneumoniae

128

212

4.17

42.47

1.1

19.28

21.81

u/l

0.65

134

Pneumonias (Asthma/COPD co-morbidities)

127

213

4.14

41.75

1.1

19.28

21.81

u/l

0.65

134

Influenza and pneumonia

129

205

4.14

41.67

1.1

19.99

21.31

u/l

0.27

131

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

128

228

4.03

41.22

1.1

22.34

19.29

u/l

0.70

144

Pneumonia, organism unspecified

118

200

4.27

41.05

1.1

18.68

20.95

u/l

0.57

128

118

171

4.33

39.49

1.1

19.20

21.18

u/l

0.40

106

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

118

171

4.33

39.49

1.1

19.20

21.18

u/l

0.40

106

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

124

218

4.00

39.32

1.1

18.77

22.04

u/l

0.97

138

Other heart diseases

9.08

39.13

1.2

1.0

20.05

23.59

u/l

0.38

Bacterial infection, other or unspecified

162

4.91

39.07

1.2

1.1

18.98

21.47

u/l

0.46

105

Non-ischemic cardiomyopathy

6.92

37.94

1.1

16.22

22.96

u/l

1.10

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

124

5.40

37.10

1.1

22.82

18.26

u/l

0.87

Other heart diseases, wide

100

134

4.63

36.07

1.2

1.1

19.47

26.59

u/l

1.85

Bacterial Sepsis

160

4.68

35.15

1.2

1.1

17.27

20.24

u/l

0.67

108

Renal tubulo-interstitial diseases

111

227

3.75

33.38

1.2

1.1

21.75

20.13

u/l

0.28

137

COPD (mode)

11.77

31.99

1.1

17.95

20.79

u/l

0.22

Suppurative and necrotic conditions of lower respiratory tract

13.23

31.45

1.0

1.2

18.60

24.33

u/l

0.34

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

6.43

31.35

1.2

21.72

15.29

u/l

1.44

Oral corticosteroids

125

218

3.47

31.11

1.1

19.85

21.30

u/l

0.29

137

Chronic kidney disease

123

5.12

30.36

1.1

23.09

17.36

u/l

0.82

Condition for Implicit Sepsis (Organ dysfunction codes)

103

201

3.73

30.18

1.2

1.1

18.82

21.44

u/l

0.56

130

Implicit Sepsis

198

3.81

29.99

1.2

1.1

18.35

21.66

u/l

0.76

128

First line medication for Crohn's disease

124

194

3.49

29.91

1.1

23.19

19.44

u/l

0.86

116

Implicit bacterial Sepsis

147

4.50

29.09

1.2

1.1

17.30

19.75

u/l

0.46

Septicaemia

146

4.56

28.73

1.2

1.1

16.86

21.05

u/l

0.86

Dyspnoea

109

246

3.40

28.44

1.1

19.30

20.61

u/l

0.25

159

Acute renal failure

6.18

28.28

1.2

21.70

17.50

u/l

0.57

Explicit Sepsis

156

4.37

28.08

1.2

1.1

16.57

20.83

u/l

0.92

104

Pyothorax

13.91

27.98

1.0

1.2

15.68

25.92

u/l

0.61

Cardiovascular diseases (excluding rheumatic etc)

6.91

27.94

1.0

27.32

25.62

u/l

0.12

Inflammatory bowel disease treatment related agents

124

219

3.22

27.05

1.1

19.32

21.38

u/l

0.45

138

ILD medications: prednisolone, methylprednisolone, prednisone

120

209

3.25

26.48

1.1

20.51

21.03

u/l

0.08

129

Valvular heart disease excluding rheumatic fever

5.04

26.32

1.2

1.1

15.38

25.57

u/l

3.24

Non-rheumatic valve diseases

5.04

26.28

1.2

1.1

15.38

25.57

u/l

3.24

Atrial fibrillation and flutter

8.03

26.10

1.3

1.1

18.27

24.71

u/l

0.84

Persons encountering health services for specific procedures and health care

114

218

3.24

25.93

1.2

1.1

21.84

20.35

u/l

0.24

141

Anaemias

14.86

25.22

1.1

1.0

19.70

24.33

u/l

—

AV-block

7.97

24.86

1.2

1.1

17.06

25.13

u/l

0.86

Fever of other and unknown origin

170

3.93

24.59

1.2

1.1

17.90

19.31

u/l

0.28

104

Cardiac arrhythmias

4.88

24.45

1.2

1.1

17.22

25.49

u/l

2.23

Other septicaemia

130

4.46

24.17

1.2

1.1

17.71

20.98

u/l

0.54

Heart failure and bmi 25plus

5.28

23.93

1.2

1.1

14.91

20.37

u/l

1.56

Asthma, unspecified (mode), excluding more controls

8.94

23.83

1.1

1.0

19.00

29.29

u/l

1.03

Later onset COPD, excluding more controls

11.52

23.63

1.2

1.1

17.33

13.91

u/l

0.38

Certain disorders involving the immune mechanism

6.47

23.42

1.1

29.18

22.21

u/l

0.63

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

6.89

22.88

1.1

1.2

27.90

14.99

u/l

1.88

Abnormal findings on diagnostic imaging of lung

201

3.59

22.56

1.2

1.1

16.51

20.38

u/l

1.12

132

ILD medications

115

209

3.02

22.54

1.1

20.88

21.03

u/l

0.02

129

Any gastric operation

4.19

22.50

1.1

26.78

19.80

u/l

1.15

GASTRO-related operations

4.19

22.50

1.1

26.78

19.80

u/l

1.15

Adjustment and management of implanted device

5.72

22.37

1.2

1.1

15.90

17.49

u/l

0.19

Other medical care

138

4.18

22.25

1.1

21.94

19.08

u/l

0.41

Abnormalities of breathing

173

3.30

22.19

1.1

19.97

21.18

u/l

0.19

106

Atrial fibrillation and flutter with reimbursement

8.26

22.08

1.3

1.0

19.71

23.54

u/l

0.37

Sarcoidosis

7.24

21.18

1.1

29.25

22.59

u/l

0.46

Conduction disorders

5.64

21.14

1.2

1.0

17.23

24.68

u/l

1.06

Diseases of the respiratory system

5.20

21.13

1.2

1.1

24.78

28.96

u/l

0.30

Dialysis, with operation codes

7.67

20.80

1.0

1.1

23.30

20.00

u/l

0.21

COPD/asthma/ILD related infections

105

171

3.08

20.53

1.2

1.1

20.53

21.18

u/l

0.10

106

COPD/asthma related infections

105

171

3.08

20.53

1.2

1.1

20.53

21.18

u/l

0.10

106

Cardiovascular diseases

6.13

20.20

1.0

1.1

24.54

27.99

u/l

0.26

ILD medications: immunosuppressive drugs

167

3.68

20.19

1.2

1.1

20.30

22.26

u/l

0.27

106

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

242

3.14

20.10

1.2

1.1

16.96

20.31

u/l

0.97

155

Hypertensive diseases (excluding secondary)

6.10

19.86

1.1

1.0

26.80

24.79

u/l

0.12

Asthma, excluding more controls

6.83

19.84

1.1

1.0

20.95

28.07

u/l

0.68

Other arrhythmias

117

3.86

18.65

1.2

1.1

16.13

26.20

u/l

3.57

Asthma (only as main-diagnosis), excluding more controls

6.70

18.22

1.1

1.0

19.17

28.07

u/l

0.87

Asthma, unspecified (mode)

6.23

17.95

1.1

1.0

19.00

23.86

u/l

0.51

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

229

2.79

17.34

1.2

1.1

19.84

21.89

u/l

0.40

137

Certain infectious and parasitic diseases

162

2.94

17.34

1.2

1.1

20.00

21.24

u/l

0.18

104

Presence of cardiac and vascular implants and grafts

152

3.34

17.17

1.2

1.1

16.94

20.43

u/l

0.78

Nephropathy related operations

6.62

17.01

1.1

1.2

24.98

24.00

u/l

0.05

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

5.86

16.77

1.1

23.80

23.89

u/l

0.01

Paroxysmal tachycardia

8.13

16.76

1.1

19.18

25.11

u/l

0.61

Pacemaker

155

3.52

16.65

1.2

1.1

15.53

18.65

u/l

0.90

100

Azathioprine

6.52

16.18

1.2

1.1

19.83

25.02

u/l

0.48

General symptoms and signs

103

193

2.68

16.03

1.1

22.17

19.96

u/l

0.37

119

Cardiomyopathy

6.15

15.90

1.0

16.12

25.06

u/l

0.96

Asthma (mode)

4.82

15.55

1.1

1.0

20.00

23.27

u/l

0.32

ILD medications: azathioprine

6.21

15.45

1.2

1.1

19.83

24.39

u/l

0.40

Valvular operations

6.69

15.29

1.1

1.0

16.93

26.16

u/l

0.93

Malignant neoplasm of respiratory system and intrathoracic organs

103

3.94

15.17

1.2

20.12

18.14

u/l

0.32

Primary_lymphoid and hematopoietic malignant neoplasms

4.51

15.12

1.1

23.82

16.00

u/l

1.00

Asthma

4.71

15.02

1.1

1.0

20.09

23.27

u/l

0.32

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

170

2.82

14.65

1.1

24.97

19.92

u/l

0.98

Malignant neoplasm, wide definition for exclusion

170

2.82

14.65

1.1

24.97

19.92

u/l

0.98

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

170

2.82

14.65

1.1

24.97

19.92

u/l

0.98

Heart failure and coronary heart disease

124

3.37

14.55

1.3

1.1

15.24

18.47

u/l

0.85

Aplastic and other anaemias

189

3.07

14.53

1.2

1.1

17.60

19.25

u/l

0.30

131

Ascites

8.31

14.51

1.0

1.1

14.43

24.00

u/l

1.00

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

4.49

14.22

1.2

23.74

14.86

u/l

1.32

Malignant neoplasm

174

2.76

14.18

1.2

1.1

25.15

19.84

u/l

1.08

Any event in cancer register

176

2.73

13.90

1.2

1.1

25.28

19.89

u/l

1.09

Fibrosis and cirrhosis of liver

7.65

13.56

1.1

1.2

13.21

24.27

u/l

0.80

Diseases of liver

134

3.44

13.39

1.1

17.39

20.46

u/l

0.56

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

4.46

13.27

1.1

26.27

16.24

u/l

1.22

Persons encountering health services in other circumstances, wide

110

245

2.33

13.26

1.2

1.1

19.75

20.89

u/l

0.20

160

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

6.60

13.19

1.1

1.2

19.41

21.67

u/l

0.13

Cerebrovascular diseases (FINNGEN)

5.57

13.16

1.1

20.58

24.84

u/l

0.44

Diseases of arteries, arterioles and capillaries (FINNGEN)

6.25

12.92

1.2

1.0

18.02

23.54

u/l

0.63

Secondary uncertain malignant neoplasm

5.12

12.67

1.2

1.3

23.21

17.90

u/l

0.42

Other disorders of fluid, electrolyte and acid-base balance

120

3.46

12.54

1.1

15.91

18.56

u/l

0.53

Asthma (only as main-diagnosis)

4.43

12.45

1.1

1.0

19.17

23.27

u/l

0.40

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

4.91

12.32

1.2

21.58

14.35

u/l

1.49

Other anaemias

181

2.94

12.28

1.2

1.1

17.23

19.29

u/l

0.37

126

Symptoms and signs involving the circulatory and respiratory systems

173

2.52

12.24

1.2

1.1

21.49

21.18

u/l

0.04

106

Cirrhosis of liver, NAS

8.06

11.89

1.1

1.2

11.55

24.85

u/l

0.85

Other and unspecified anaemias

180

2.91

11.86

1.2

1.1

17.46

19.29

u/l

0.31

126

Hypertensive diseases

133

2.81

11.81

1.2

1.1

24.16

20.88

u/l

0.38

Hypertension

133

2.81

11.80

1.2

1.1

24.16

20.88

u/l

0.38

Hypertension, essential

132

2.81

11.67

1.2

1.1

22.48

20.89

u/l

0.18

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

4.52

11.40

1.0

1.3

18.79

20.07

u/l

0.11

Polyarthropathies

176

2.61

11.38

1.1

19.21

20.01

u/l

0.14

115

Explicit bacterial Sepsis

5.90

11.31

1.0

1.1

12.84

24.68

u/l

1.42

Oxycodone

129

3.23

11.30

1.2

1.1

24.55

17.30

u/l

1.27

Cardiomyopathies, Primary/intrinsic

5.96

10.85

1.0

14.76

27.04

u/l

—

Cardiomyopathy (excluding other)

5.95

10.85

1.0

14.76

28.04

u/l

—

Primary_lymphoid and hematopoietic malignant neoplasms

103

3.50

10.83

1.1

1.2

23.82

17.67

u/l

0.71

Hypertensive heart and/or renal disease

3.83

10.78

1.1

1.0

16.70

17.57

u/l

0.16

Infections, IBD-co-morbidities

4.87

10.75

1.3

1.1

20.18

19.41

u/l

0.05

Enlarged lymph nodes

4.72

10.69

1.1

25.14

18.92

u/l

0.64

Parasetamol

135

2.61

10.49

1.2

1.1

19.67

21.77

u/l

0.27

Ischemic heart diseases

200

2.38

10.24

1.2

1.1

17.10

20.78

u/l

0.94

135

Cardiodefibrillation

169

2.84

10.24

1.1

19.46

18.63

u/l

0.11

116

Bacterial pneumonia, not elsewhere classified

124

3.07

10.23

1.2

1.1

20.74

18.40

u/l

0.41

Neoplasms

108

2.83

10.20

1.1

26.10

19.11

u/l

1.14

Dentinal caries

3.72

10.19

1.1

23.70

23.00

u/l

0.05

Bacterial pneumoniae

129

3.02

10.19

1.2

1.1

20.74

18.56

u/l

0.38

Diagnoses used for exclusion with ILD

123

3.18

10.10

1.1

27.12

19.44

u/l

0.89

Viral pneumonia

6.09

9.91

1.2

20.78

27.18

u/l

—

Diabetes, varying definitions

227

2.24

9.88

1.2

1.1

22.14

21.07

u/l

0.13

156

Diabetes mellitus

227

2.24

9.85

1.2

1.1

22.14

21.07

u/l

0.13

156

Dental caries

3.53

9.73

1.1

24.34

22.89

u/l

0.11

Opioids

185

2.30

9.66

1.2

1.1

20.99

19.80

u/l

0.16

119

Second line medication for Crohn's disease

199

2.62

9.52

1.2

1.1

19.46

21.81

u/l

0.43

134

Any reimbursement code in KELA

3.81

9.45

1.1

1.0

26.66

26.30

u/l

0.02

Benign neoplasm of colon, rectum, anus and anal canal

125

2.80

9.44

1.1

16.14

18.82

u/l

0.56

Implicit viral Sepsis

3.95

9.30

1.2

1.1

19.63

21.30

u/l

0.15

Viral Sepsis

3.95

9.30

1.2

1.1

19.63

21.30

u/l

0.15

Other disorders of kidney and ureter

4.51

9.29

1.3

1.2

23.29

19.87

u/l

0.18

Pain in throat and chest

171

2.40

9.14

1.1

22.07

21.18

u/l

0.11

105

Coronary atherosclerosis

182

2.38

9.11

1.2

1.1

16.26

20.37

u/l

1.35

125

Insulin medication

213

2.41

9.01

1.2

1.1

19.37

20.51

u/l

0.15

144

Persons encountering health services for other counselling and medical advice, not elsewhere classified

241

2.11

8.88

1.1

19.71

20.99

u/l

0.20

157

Care involving dialysis

6.02

8.65

1.0

1.1

28.66

22.54

u/l

—

Streptococcal septicaemia

6.02

8.65

1.0

1.2

12.74

25.29

u/l

—

Benign neoplasms

117

2.61

8.58

1.1

22.45

19.36

u/l

0.47

L04AX Other immunosuppressants

198

2.53

8.58

1.2

1.1

19.62

21.81

u/l

0.39

134

Hard cardiovascular diseases

208

2.22

8.46

1.2

1.1

18.52

20.08

u/l

0.29

140

Acute tubulo-interstitial nephritis

191

2.46

8.42

1.2

1.1

19.29

19.14

u/l

0.01

120

Type 2 diabetes, wide definition

210

2.20

8.23

1.2

1.1

19.32

20.57

u/l

0.17

145

Glomerular diseases

3.52

8.22

1.0

1.2

20.72

20.01

u/l

0.04

Non-small cell lung cancer

3.47

8.07

1.2

21.58

18.06

u/l

0.43

Insulin, intermediate and long-acting

230

2.35

8.05

1.2

1.1

20.49

20.63

u/l

0.01

150

Continuous positive airway pressure

4.69

8.05

1.1

18.02

22.88

u/l

0.60

Antihypertensive medication - note that there are other indications

3.41

8.00

1.1

25.56

26.59

u/l

0.05

Benign neoplasm: Colon

122

2.70

7.96

1.1

14.86

18.88

u/l

0.91

Chronic periapical parodontitis

3.52

7.95

1.1

23.01

23.32

u/l

0.02

Type 2 diabetes, strict (exclude DM1)

222

2.10

7.86

1.2

1.1

20.60

20.88

u/l

0.03

151

Type 2 diabetes

225

2.09

7.83

1.2

1.1

19.26

21.04

u/l

0.25

154

Diseases of pulp and periapical tissues

121

2.90

7.82

1.1

21.52

22.57

u/l

0.08

Ischaemic heart disease, wide definition

202

2.17

7.76

1.2

1.1

17.55

20.60

u/l

0.67

137

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

225

2.09

7.74

1.2

1.1

19.96

21.09

u/l

0.14

154

Diseases of arteries, arterioles and capillaries

227

2.17

7.64

1.1

16.10

20.14

u/l

1.37

152

Insulin, combination of fast acting with intermediate-acting or long-acting

250

2.21

7.61

1.2

1.1

19.37

20.26

u/l

0.11

165

Erysipelas

175

2.45

7.49

1.1

16.08

21.66

u/l

1.65

112

Type 2 diabetes, definitions combined

219

2.07

7.44

1.2

1.1

20.85

20.59

u/l

0.03

149

Transplanted organ and tissue status

5.40

7.24

1.1

23.78

29.31

u/l

—

Diseases of the skin and subcutaneous tissue

207

2.01

7.20

1.2

1.1

23.29

20.44

u/l

0.43

138

Other bacterial intestinal infections

3.44

7.10

1.3

1.2

21.36

20.88

u/l

0.03

Diabetes, insulin treatment (Kela reimbursement)

255

1.97

7.06

1.2

1.1

20.29

21.04

u/l

0.09

173

Other chronic obstructive pulmonary disease

173

2.36

7.05

1.2

1.1

18.05

19.02

u/l

0.19

120

Hypertensive Heart Disease

3.33

6.96

1.1

1.0

17.73

17.95

u/l

0.03

Bacterial pneumonia (organism specified)

188

2.33

6.86

1.2

1.1

20.85

19.07

u/l

0.34

124

COPD-related respiratory insufficiency

4.01

6.61

1.3

1.2

16.06

18.16

u/l

0.19

Malaise and fatigue

153

2.40

6.61

1.3

1.1

21.67

18.51

u/l

0.38

Provisional assignment of new diseases of uncertain etiology

163

2.46

6.56

1.2

1.1

23.41

21.09

u/l

0.26

105

Codes for special purposes

163

2.46

6.56

1.2

1.1

23.41

21.09

u/l

0.26

105

Glomerular disorders in diseases classified elsewhere

4.16

6.54

1.0

1.2

22.61

22.12

u/l

0.02

Bacterial intestinal infections, IBD co-morbidities

3.34

6.54

1.3

1.2

21.05

u/l

0.00

COPD

178

2.27

6.51

1.2

1.1

18.05

19.44

u/l

0.30

125

Metabolic disorders

229

1.98

6.47

1.2

1.1

21.12

20.33

u/l

0.09

145

Diseases of oesophagus, stomach and duodenum

266

1.90

6.46

1.1

19.72

20.33

u/l

0.11

164

ILD, hospital admissions 3, with pneumonia sepsis

5.47

6.28

1.2

1.3

19.00

24.11

u/l

—

Calcific aortic valvular stenosis, operated

151

2.47

6.27

1.2

1.1

16.23

18.05

u/l

0.40

100

Calcific aortic valvular stenosis

151

2.47

6.27

1.2

1.1

16.23

18.05

u/l

0.40

100

Operations 2 for CAVS

151

2.47

6.27

1.2

1.1

16.23

18.05

u/l

0.40

100

Calcific aortic valvular stenosis, diagnosis (helper)

151

2.47

6.27

1.2

1.1

16.23

18.05

u/l

0.40

100

Calcific aortic valvular stenosis, including rheumatic fever

151

2.46

6.26

1.2

1.1

16.23

18.05

u/l

0.40

100

All influenza

3.24

6.26

1.0

1.1

27.33

20.02

u/l

0.63

Coronary revascularization (ANGIO or CABG)

151

2.27

6.25

1.2

1.1

14.34

19.52

u/l

1.81

101

Other respiratory disorders and diseases

2.94

6.25

1.3

1.2

16.82

19.46

u/l

0.40

Other diseases of the respiratory system

2.94

6.25

1.3

1.2

16.82

19.46

u/l

0.40

Cyst of kidney

5.02

6.22

1.3

1.2

19.29

23.94

u/l

—

Type 2 diabetes, definitions combined, including avohilmo

221

1.96

6.19

1.2

1.1

20.57

20.89

u/l

0.04

150

Oedema, not elsewhere classified

114

2.71

6.19

1.2

1.1

22.24

18.06

u/l

0.35

Enterocolitis due to Clostridium difficile

3.96

6.16

1.4

1.2

15.56

21.04

u/l

0.53

Bleeding

267

1.94

6.12

1.1

18.38

20.13

u/l

0.32

172

Endocrine, nutritional and metabolic diseases

137

2.16

6.07

1.3

1.1

21.32

22.86

u/l

0.16

Major coronary heart disease event

213

2.01

5.99

1.3

1.1

17.57

19.90

u/l

0.49

141

Glucagon-like peptide-1 (GLP-1) analogues

201

2.13

5.95

1.2

1.1

18.50

19.85

u/l

0.15

142

Diabetes medication

248

1.89

5.95

1.2

1.1

19.58

20.84

u/l

0.16

168

COPD, hospital admissions

191

2.17

5.93

1.2

1.1

18.05

19.35

u/l

0.28

128

Other disorders of teeth and supporting structures

3.04

5.90

1.1

18.73

23.20

u/l

0.64

Benign neoplasms

223

1.90

5.90

1.1

19.82

21.07

u/l

0.21

145

COPD, early/later onset

191

2.17

5.89

1.2

1.1

18.05

19.35

u/l

0.28

128

Gastric ulcer

3.01

5.78

1.0

1.2

16.34

17.91

u/l

0.17

Abnormal findings on examination of blood, without diagnosis

209

2.15

5.78

1.2

1.1

17.50

19.69

u/l

0.39

136

Other chronic obstructive pulmonary disease, including avohilmo

206

2.10

5.78

1.2

1.1

17.88

19.77

u/l

0.47

140

Thrombocytopenia, unspecified

5.02

5.74

1.0

1.3

22.54

17.53

u/l

—

Codeine

183

1.98

5.73

1.1

22.77

19.76

u/l

0.43

117

Hypo-osmolality and hyponatraemia

3.14

5.70

1.1

1.2

13.21

18.49

u/l

0.75

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

3.30

5.69

1.1

1.0

25.53

20.87

u/l

0.25

Gout

114

2.56

5.66

1.1

19.67

17.22

u/l

0.39

Diabetic nephropathy, excluding more controls

3.31

5.66

1.0

1.1

21.18

16.39

u/l

0.24

Autoimmune diseases excluding thyroid diseases, strict definition

230

1.87

5.66

1.2

1.1

21.45

21.00

u/l

0.05

142

Gout, strict definition

2.88

5.61

1.0

1.2

18.91

19.06

u/l

0.01

Iron deficiency anaemia

175

2.27

5.53

1.1

1.2

15.89

19.42

u/l

1.05

119

Hyperlipidaemia, other/unspecified

155

2.32

5.52

1.2

1.1

20.71

18.73

u/l

0.19

100

Emergency coronary revascularization (for ACS)

194

2.04

5.50

1.2

1.1

14.73

19.36

u/l

1.72

124

ILD, hospital admission 2, with pulmonary infections

4.81

5.49

1.2

19.00

21.73

u/l

—

Finngen Rheumatological endpoints

214

1.89

5.48

1.2

1.1

19.05

21.50

u/l

0.54

144

In situ neoplasms

2.68

5.30

1.1

20.05

17.81

u/l

0.29

Insulin, fast-acting

149

2.35

5.28

1.3

1.1

20.30

20.69

u/l

0.03

Arthropathies

182

1.90

5.20

1.1

23.27

20.38

u/l

0.37

119

Other and unspecified iron deficiency

132

2.43

5.18

1.1

1.2

15.90

19.99

u/l

0.97

Nutritional anaemias

209

2.10

5.16

1.1

1.2

15.95

19.80

u/l

1.36

140

Major coronary heart disease event excluding revascularizations

205

1.95

5.15

1.3

1.1

17.50

19.96

u/l

0.51

136

Autoimmune diseases excluding thyroid diseases

241

1.80

5.13

1.2

1.1

21.59

20.96

u/l

0.07

151

Coagulation defects, purpura and other haemorrhagic conditions

3.08

5.05

1.0

1.2

34.46

19.69

u/l

0.75

Diseases of oral cavity, salivary glands and jaws

208

1.83

5.03

1.1

17.90

20.45

u/l

0.61

138

COPD related to multimorbidity

171

2.12

4.95

1.2

1.1

17.89

18.73

u/l

0.16

114

Covid-19 confirmed case

112

2.50

4.85

1.3

1.1

22.35

20.00

u/l

0.26

Benign neoplasm of colon, rectum, anus and anal canal

249

1.92

4.76

1.1

16.32

19.53

u/l

0.86

163

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

269

1.77

4.75

1.1

19.41

20.48

u/l

0.15

176

Codeine or tramadol medication

269

1.71

4.66

1.1

22.74

19.96

u/l

0.52

175

Autoimmune diseases related-to ILD

290

1.82

4.57

1.2

1.1

20.88

20.33

u/l

0.07

189

Insulin, fast-acting or short human

160

2.19

4.53

1.3

1.1

20.30

20.37

u/l

0.01

107

Other (not insulin) diabetes medications

240

1.76

4.44

1.2

1.1

19.07

20.72

u/l

0.24

162

Other diseases of blood and blood-forming organs, wide

2.62

4.38

1.0

1.2

20.50

21.74

u/l

0.13

Gastroduodenal ulcer

124

2.34

4.37

1.1

1.2

17.62

17.38

u/l

0.02

Use of hypnotics and sedatives

261

1.71

4.37

1.1

24.00

19.47

u/l

0.85

165

Gout, FINNGEN

144

2.23

4.32

1.1

19.67

18.13

u/l

0.21

Venous thromboembolism

240

1.90

4.19

1.1

21.36

18.48

u/l

0.36

163

Genitourinary diseases

111

2.03

4.18

1.2

1.0

23.81

20.56

u/l

0.34

Coronary artery bypass grafting

109

2.24

4.16

1.2

1.1

13.65

19.70

u/l

1.71

Symptoms and signs involving the digestive system and abdomen

220

1.71

4.15

1.1

21.42

19.36

u/l

0.31

140

DVT of lower extremities and pulmonary embolism

193

2.02

4.12

1.1

1.2

21.67

18.24

u/l

0.36

132

Biguanides

247

1.72

4.12

1.1

19.82

20.86

u/l

0.13

167

Purpura and other haemorrhagic conditions

3.20

4.05

1.0

1.2

20.11

19.18

u/l

—

Peripheral artery disease

177

1.96

4.04

1.2

1.1

15.08

19.09

u/l

1.15

116

COPD, hospital admission 2, with asthma infections

142

2.10

4.03

1.2

1.1

18.75

18.84

u/l

0.01

Gastrointestinal diseases

2.10

3.96

1.2

1.1

23.60

21.30

u/l

0.19

Diseases of the digestive system

211

1.94

3.91

1.0

1.1

17.96

19.81

u/l

0.38

142

Factors influencing health status and contact with health services

2.62

3.86

1.2

1.0

22.56

22.17

u/l

0.02

Gout, idiopatic and unspecified

126

2.23

3.82

1.1

1.2

18.76

18.04

u/l

0.08

Pulmonary heart disease, diseases of pulmonary circulation

146

2.12

3.78

1.1

18.08

18.64

u/l

0.09

Other embolism and thrombosis

3.01

3.68

1.1

1.3

25.78

21.88

u/l

—

231

1.82

3.68

1.0

1.1

22.25

19.22

u/l

0.53

149

Tramadol

181

1.81

3.68

1.1

21.17

19.38

u/l

0.26

116

Alcohol use disorder, Swedish definition

220

1.86

3.67

1.0

1.1

22.46

19.30

u/l

0.52

143

Other diseases of intestines

246

1.65

3.62

1.1

21.00

20.35

u/l

0.09

156

Complications of surgical and medical care, not elsewhere classified

296

1.65

3.62

1.2

1.1

19.46

20.80

u/l

0.23

189

226

1.83

3.58

1.0

1.1

22.85

19.20

u/l

0.68

146

Gingivitis and periodontal diseases

206

1.68

3.57

1.1

19.63

20.52

u/l

0.13

137

Senile cataract

176

1.80

3.57

1.2

1.1

21.65

19.46

u/l

0.23

117

Sleep apnoea, including avohilmo

263

1.65

3.55

1.1

22.24

20.42

u/l

0.29

185

Nausea and vomiting

2.38

3.49

1.1

1.2

20.76

18.40

u/l

0.36

Direct fill therapy

3.17

3.49

1.1

26.29

23.30

u/l

—

Unstable angina pectoris

152

1.96

3.48

1.2

1.1

18.12

17.98

u/l

0.02

Abnormal findings on diagnostic imaging of other body structures

3.34

3.47

1.1

12.77

24.70

u/l

—

GI-bleeding

152

2.04

3.44

1.1

1.2

17.00

18.87

u/l

0.31

Disorders of lens

192

1.74

3.38

1.2

1.1

21.48

19.63

u/l

0.20

127

STROKE

137

1.93

3.37

1.1

20.61

21.79

u/l

0.13

Diabetic nephropathy

2.39

3.36

1.0

1.2

21.18

18.23

u/l

0.14

Abnormalities of heart beat

119

2.17

3.36

1.3

1.1

18.34

19.14

u/l

0.11

Atherosclerosis, excluding cerebral and coronary sclerosis

171

1.87

3.35

1.2

1.1

15.85

19.10

u/l

0.76

112

Other specified/unspecified arthritis

101

2.28

3.35

1.2

1.1

18.75

18.96

u/l

0.02

Sleep disorders (combined)

271

1.62

3.32

1.1

21.91

20.67

u/l

0.20

186

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

3.19

3.27

1.2

18.71

19.74

u/l

—

Intestinal infectious diseases

296

1.63

3.25

1.2

1.1

21.96

19.91

u/l

0.28

195

Chronic lower respiratory diseases

275

1.55

3.18

1.1

17.80

21.29

u/l

1.21

185

Later onset COPD

122

2.00

3.14

1.2

1.1

16.96

18.12

u/l

0.21

Other diseases of the digestive system

151

1.99

3.13

1.1

1.2

17.00

18.74

u/l

0.28

Sleep apnoea

265

1.61

3.11

1.1

20.73

20.67

u/l

0.01

185

Actinic keratosis

170

1.90

3.10

1.1

22.21

17.47

u/l

0.47

115

Angina pectoris

177

1.76

3.08

1.2

1.1

18.06

20.63

u/l

0.44

120

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

3.24

3.05

1.3

1.2

22.63

15.06

u/l

—

Barrett oesophagus

5.02

3.05

1.1

19.05

35.53

u/l

—

Other joint disorders

182

1.67

3.04

1.1

22.75

20.38

u/l

0.28

119

Haemorrhage from respiratory passages

122

2.05

3.04

1.1

18.02

19.09

u/l

0.16

Benign neoplasm: Colon

241

1.75

3.04

1.1

14.86

19.68

u/l

1.34

162

Syncope and collapse

148

1.92

2.97

1.2

1.1

14.93

18.37

u/l

0.97

Ulcer of lower limb, not elsewhere classified

2.64

2.96

1.1

1.2

14.79

22.73

u/l

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

118

1.93

2.95

1.2

1.1

20.66

18.14

u/l

0.22

Fitting and adjustment of other devices

124

2.03

2.95

1.1

14.12

18.47

u/l

0.79

Skin changes due to chronic exposure to nonionizing radiation

173

1.86

2.93

1.1

22.21

17.49

u/l

0.46

118

Statin medication

152

1.73

2.92

1.2

1.1

26.70

19.91

u/l

0.73

106

Pulmonary heart disease

135

2.00

2.89

1.1

18.29

18.44

u/l

0.02

Used for control exclusion in common control thyroid runs

223

1.57

2.89

1.2

1.1

18.52

21.04

u/l

0.42

136

Hepatic failure, not elsewhere classified

5.41

2.87

1.3

1.1

14.26

28.41

u/l

—

Other arthritis (FG)

122

2.05

2.86

1.2

1.1

19.46

20.91

u/l

0.16

Pulmonary embolism

136

1.99

2.84

1.1

18.29

18.43

u/l

0.02

Fall on same level

266

1.53

2.84

1.1

19.47

21.36

u/l

0.40

177

L04AA Selective immunosuppressants

2.34

2.81

1.4

1.1

19.43

23.72

u/l

0.19

Symptoms and signs involving the urinary system

264

1.61

2.80

1.2

1.1

15.65

20.63

u/l

1.67

170

Complications of procedures, not elsewhere classified

290

1.61

2.79

1.2

1.1

20.41

20.83

u/l

0.05

184

Myocardial infarction

163

1.76

2.78

1.3

1.1

17.54

19.99

u/l

0.39

109

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

122

1.92

2.75

1.1

22.59

18.24

u/l

0.42

COPD, hospital admissions 3, with asthma pneumonia sepsis

116

1.98

2.75

1.2

18.79

18.01

u/l

0.11

Coronary angioplasty

131

1.88

2.74

1.3

1.1

15.31

18.92

u/l

0.70

Disorders of lipoprotein metabolism and other lipidaemias

209

1.62

2.74

1.2

1.1

19.97

19.94

u/l

0.00

132

Systemic connective tissue disorders

138

1.96

2.74

1.2

21.71

20.50

u/l

0.16

183

1.80

2.74

1.1

21.84

17.59

u/l

0.43

125

Seronegative rheumatoid arthritis

2.98

2.69

1.1

1.2

17.40

23.98

u/l

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

118

1.87

2.67

1.3

1.1

20.66

18.14

u/l

0.22

Familial hypercholesterolemia

2.33

2.64

1.1

18.18

18.51

u/l

0.03

Falls/tendency to fall

234

1.52

2.62

1.2

1.1

18.29

21.77

u/l

0.94

153

Other specific joint derangements/joint disorders

175

1.69

2.61

1.1

19.99

20.75

u/l

0.12

113

Other and unspecified effects of external causes

2.25

2.60

1.2

1.1

21.15

23.95

u/l

0.21

Rheumatoid arthritis

115

1.98

2.58

1.2

1.1

18.11

18.27

u/l

0.02

Other (seronegative) rheumatoid arthritis, wide

2.36

2.55

1.1

20.33

22.24

u/l

—

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

2.73

2.54

1.3

1.2

22.63

14.08

u/l

—

Other and unspecified polyneuropathies, also in other diseases

2.13

2.54

1.1

1.2

22.44

19.40

u/l

—

Parodontitis or/and operation codes

129

1.75

2.52

1.1

22.37

20.03

u/l

0.17

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

120

1.83

2.51

1.3

1.1

20.66

18.37

u/l

0.20

Peripheral arterial reconstruction

2.16

2.50

1.3

1.2

12.72

18.31

u/l

1.34

Other special examinations and investigations of persons without complaint or reported diagnosis

148

1.64

2.45

1.3

1.1

19.77

19.56

u/l

0.01

100

258

1.47

2.36

1.1

21.12

20.23

u/l

0.14

170

Disorders of other endocrine glands

165

1.79

2.36

1.2

1.1

27.79

19.90

u/l

0.64

108

Diseases of the myoneural junction and muscle

2.61

2.35

1.0

1.2

25.14

20.57

u/l

—

Polyneuropathies and other disorders of the peripheral nervous system

104

2.02

2.35

1.1

1.2

21.60

19.71

u/l

—

Any mental disorder

261

1.46

2.34

1.1

21.61

20.03

u/l

0.21

172

Cerebrovascular diseases

251

1.54

2.32

1.1

21.09

19.27

u/l

0.32

174

In situ neoplasms

147

1.84

2.32

1.1

1.2

20.05

18.92

u/l

0.13

103

Autoimmune diseases

242

1.48

2.31

1.2

1.1

20.33

20.96

u/l

0.07

151

Dental caries 3

205

1.52

2.31

1.1

18.23

19.59

u/l

0.24

133

Dental pulpitis 1

255

1.47

2.31

1.1

21.30

20.26

u/l

0.14

169

Dental caries, including avohilmo

193

1.54

2.30

1.1

18.17

19.12

u/l

0.16

125

Dental caries 1

193

1.54

2.30

1.1

18.17

19.12

u/l

0.16

125

Parodontitis or operation codes

283

1.51

2.28

1.1

21.27

20.09

u/l

0.12

186

Benzodiazepine use

302

1.48

2.28

1.1

21.62

20.15

u/l

0.19

196

Presence of other functional implants

166

1.66

2.27

1.2

1.1

18.04

21.31

u/l

0.40

105

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

134

1.73

2.27

1.2

1.1

20.69

18.53

u/l

0.19

Rheumatoid arthritis, including avohilmo

156

1.80

2.24

1.1

17.62

20.08

u/l

0.36

110

Intracranial trauma

165

1.68

2.24

1.2

1.1

17.55

20.83

u/l

0.61

114

General examination and investigation of persons without complaint and reported diagnosis

148

1.62

2.23

1.2

1.1

16.01

19.56

u/l

0.94

100

Diarrhoea and gastroenteritis of presumed infectious origin

252

1.59

2.23

1.1

22.87

20.15

u/l

0.29

165

Dental caries 1 and operation codes

213

1.49

2.18

1.1

19.26

19.58

u/l

0.05

137

External causes of morbidity and mortality

144

1.60

2.17

1.3

1.1

24.26

21.48

u/l

0.28

Congenital malformations, deformations and chromosomal abnormalities

194

1.68

2.17

1.1

21.45

23.33

u/l

0.21

129

Neurological diseases

193

1.51

2.16

1.1

24.62

19.92

u/l

0.54

133

Benign neoplasm: Parotid gland

3.69

2.15

1.4

1.2

20.26

18.09

u/l

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

290

1.47

2.15

1.1

20.59

20.57

u/l

0.00

189

Complications of medical and surgical care

289

1.54

2.15

1.2

1.1

20.06

20.52

u/l

0.06

186

Thyrotoxicosis

2.16

2.14

1.2

1.1

16.42

23.48

u/l

1.03

Diseases of the musculoskeletal system and connective tissue

106

1.70

2.14

1.2

1.1

21.08

22.22

u/l

0.08

Medical observation and evaluation for suspected diseases and conditions

148

1.59

2.14

1.2

1.1

21.95

19.56

u/l

0.36

100

Chronic periodontitis, including avohilmo

283

1.49

2.14

1.1

20.00

20.42

u/l

0.04

186

Accidents

189

1.51

2.11

1.2

1.1

20.50

21.76

u/l

0.16

123

Dental pulpitis 4

256

1.44

2.11

1.1

21.48

20.26

u/l

0.16

169

Gout, unspecified

102

1.96

2.09

1.1

1.2

19.82

17.93

u/l

0.17

ILD, hospital admissions 1, main diag only

2.26

2.07

1.2

1.3

18.86

19.65

u/l

—

Parodontitis

284

1.48

2.07

1.1

20.00

20.34

u/l

0.03

187

Other antidepressants

254

1.44

2.07

1.1

22.08

19.76

u/l

0.35

165

Other respiratory diseases principally affecting the interstitium

2.08

2.06

1.2

18.22

19.73

u/l

—

Concussion

165

1.68

2.02

1.2

1.1

18.41

20.83

u/l

0.39

114

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.63

2.00

1.0

1.1

22.40

26.27

u/l

—

Hernia

274

1.46

2.00

1.2

1.1

17.23

21.00

u/l

0.94

180

Diseases of pulp and periapical tissues, including avohilmo

255

1.43

1.99

1.1

21.48

20.26

u/l

0.16

169

Mental and behavioural disorders due to alcohol

210

1.62

1.99

1.1

22.93

19.74

u/l

0.54

136

ILD, hospital admissions

2.15

1.98

1.2

19.38

19.44

u/l

—

Dental caries 3 and operation codes

223

1.45

1.95

1.1

20.05

19.99

u/l

0.01

143

Stroke, including SAH

229

1.52

1.95

1.1

21.14

18.93

u/l

0.35

161

Volume depletion

2.57

1.92

1.0

1.2

16.23

18.20

u/l

—

Interstitial lung disease

2.12

1.92

1.2

19.38

19.44

u/l

—

Other interstitial pulmonary diseases

2.12

1.92

1.2

19.38

19.44

u/l

—

Interstitial lung disease endpoints

2.12

1.92

1.2

19.38

19.44

u/l

—

Episodal and paroxysmal disorders

245

1.42

1.91

1.2

1.1

22.73

19.68

u/l

0.44

162

Substance abuse, excluding more controls

211

1.58

1.90

1.1

22.27

19.20

u/l

0.55

137

Pain, not elsewhere classified

2.00

1.89

1.1

23.10

20.03

u/l

—

TMD related operations

0.00

1.88

0.0

1.1

—

25.12

—

Pain (limb, back, neck, head abdominally)

170

1.50

1.88

1.3

1.1

18.98

19.62

u/l

0.06

116

Other and unspecified drugs and medicaments

3.19

1.88

1.6

1.2

16.99

26.16

u/l

—

Dermatitis and eczema

302

1.41

1.85

1.1

18.13

21.05

u/l

0.61

195

Other bursopathies

0.00

1.85

0.0

1.0

—

21.70

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

197

1.62

1.85

1.1

23.32

19.47

u/l

0.62

129

Benign neoplasm: Rectosigmoid junction

4.18

1.82

1.0

1.3

25.20

18.05

u/l

—

COPD, hospital admissions 1, only main diagnosis

161

1.64

1.82

1.2

1.1

16.98

18.63

u/l

0.30

107

Substance abuse

234

1.55

1.82

1.1

22.27

19.56

u/l

0.46

152

Type 1 diabetes

1.95

1.78

1.1

21.40

20.33

u/l

0.04

Neurological diseases, wide definition

2.01

1.76

1.1

23.17

20.14

u/l

0.12

Other specified/unspecified systemic involvement of connective tissue

3.34

1.74

1.2

1.1

19.83

27.86

u/l

—

Other disorders of skin and subcutaneous tissue

271

1.49

1.74

1.2

1.1

16.15

20.49

u/l

1.06

179

Other functional intestinal disorders

176

1.62

1.74

1.3

1.1

20.69

17.49

u/l

0.46

112

Disorders of calcium metabolism

2.92

1.72

1.3

1.2

50.57

17.66

u/l

—

Benign neoplasm of major salivary glands

2.92

1.72

1.4

1.2

20.26

16.94

u/l

—

Persons encountering health services in other circumstances

125

1.76

1.70

1.0

1.1

14.54

22.25

u/l

2.01

Myocardial infarction, strict

157

1.58

1.70

1.3

1.1

15.26

19.54

u/l

1.14

106

Unspecified haematuria

173

1.59

1.67

1.1

15.04

19.66

u/l

1.10

116

Benign neoplasm: Parotid gland

2.80

1.65

1.4

1.2

20.26

25.50

u/l

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

2.80

1.65

1.6

1.2

16.99

24.53

u/l

—

Infections of the skin and subcutaneous tissue

219

1.55

1.64

1.2

1.1

21.29

21.15

u/l

0.01

150

Disorders of parathyroid gland

1.98

1.63

1.2

39.20

20.31

u/l

—

Psychiatric diseases

256

1.37

1.63

1.1

21.63

20.22

u/l

0.17

170

Benign neoplasm: Colon, unspecified

1.97

1.62

1.1

12.98

16.48

u/l

—

Implicit fungal Sepsis

3.58

1.61

1.0

1.1

21.94

33.16

u/l

—

Fungal Sepsis

3.58

1.61

1.0

1.1

21.94

33.16

u/l

—

Generalized skin eruption due to drugs and medicaments

3.58

1.61

1.6

1.1

9.64

29.03

u/l

—

Acute generalized exanthematous pustulosis

3.58

1.61

1.6

1.1

9.64

29.03

u/l

—

Intestinal malabsorption

3.58

1.61

1.0

1.1

16.94

30.59

u/l

—

Other external causes of accidental injury

189

1.43

1.61

1.2

1.1

20.66

21.76

u/l

0.13

123

Fall on and from stairs and steps

1.84

1.61

1.1

1.2

23.56

20.06

u/l

—

Mental and behavioural disorders due to psychoactive substance use

239

1.50

1.60

1.1

22.27

19.54

u/l

0.47

155

Other soft tissue disorders, not elsewhere classified

241

1.41

1.58

1.2

1.1

22.61

20.32

u/l

0.28

152

Ulcer of oesophagus

3.00

1.58

1.0

1.2

19.83

26.61

u/l

—

Hyperplasia of prostate

115

1.59

1.57

1.4

1.0

16.54

17.40

u/l

0.13

Reimbursement for rheumatic diseases

238

1.51

1.57

1.2

1.1

17.42

21.07

u/l

0.63

163

Neurotic, stress-related and somatoform disorders

226

1.45

1.56

1.1

24.78

21.29

u/l

0.36

151

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

114

1.76

1.56

1.1

20.29

22.79

u/l

0.27

Urticaria and erythema

122

1.72

1.54

1.1

25.77

22.42

u/l

0.21

Pain in limb

237

1.43

1.53

1.2

1.1

22.54

20.40

u/l

0.25

150

Other and unspecified disorders of white blood cells

3.34

1.52

1.0

1.1

22.54

27.23

u/l

—

Benign neoplasm: Kidney

3.34

1.52

2.0

1.1

21.76

27.23

u/l

—

Other diseases of urinary system

259

1.37

1.52

1.2

1.1

21.62

20.30

u/l

0.18

170

Benign neoplasm: salivary glands, exclude unknown (D119)

2.60

1.51

1.4

1.2

20.26

24.56

u/l

—

Long labour

0.00

1.50

0.0

1.1

—

32.67

—

Other viral diseases

1.86

1.48

1.1

23.31

23.22

u/l

—

Retention of urine

143

1.60

1.47

1.3

1.1

17.68

19.45

u/l

0.25

Anxiety disorders, excluding more controls

208

1.43

1.46

1.1

24.97

21.38

u/l

0.36

138

Abdominal and pelvic pain

220

1.37

1.44

1.2

1.1

23.60

19.36

u/l

0.62

140

Other diseases of peritoneum

3.13

1.44

1.0

1.1

34.20

28.57

u/l

—

Other diseases of liver

2.04

1.43

1.2

18.00

22.73

u/l

—

Other reaction to severe stress, and adjustment disorders

103

1.75

1.40

1.1

19.03

23.77

u/l

0.57

Arthrosis

173

1.43

1.40

1.2

1.1

19.45

19.74

u/l

0.04

113

Stroke, excluding SAH

224

1.43

1.39

1.0

1.1

21.85

18.99

u/l

0.45

158

Primary gonarthrosis, bilateral

219

0.56

1.37

1.1

15.50

19.95

u/l

—

146

Disorders of gallbladder, biliary tract and pancreas

287

1.35

1.37

1.1

17.92

20.73

u/l

0.75

184

Urticaria

1.80

1.36

1.1

26.92

22.79

u/l

—

Benign neoplasm: Rectosigmoid junction

2.95

1.36

1.0

1.2

25.20

27.66

u/l

—

All anxiety disorders

152

1.54

1.36

1.1

27.81

22.61

u/l

0.42

101

Asthma-related pneumonia

166

1.56

1.36

1.2

1.1

18.15

18.97

u/l

0.11

112

Anxiety disorders

233

1.40

1.34

1.1

24.78

21.25

u/l

0.37

157

Use of galantamine

0.00

1.34

0.0

1.3

—

23.40

—

Combinations of oral blood glucose lowering drugs

120

1.67

1.33

1.1

15.59

19.84

u/l

0.60

Benign neoplasm of other and ill-defined parts of digestive system

2.13

1.33

1.2

1.1

16.62

16.48

u/l

—

Parodontitis and operation codes

283

1.37

1.33

1.1

20.50

20.44

u/l

0.01

186

Asthma, hospital admissions 3, pneumonia

167

1.56

1.33

1.2

1.1

18.15

19.01

u/l

0.12

113

Asthma-related pneumonia or sepsis

167

1.56

1.33

1.2

1.1

18.15

19.01

u/l

0.12

113

Care involving use of rehabilitation procedures

197

1.49

1.32

1.3

1.1

17.88

19.87

u/l

0.26

128

Bronchitis

300

1.33

1.32

1.1

21.68

19.99

u/l

0.30

197

Preparation and fitting of bite rail to mouth

0.00

1.31

0.0

1.1

—

24.64

—

Malignant neoplasm of skin

237

1.40

1.30

1.2

1.1

19.84

18.71

u/l

0.12

155

Exclusions for E4_PCOS_CONSORTIUM

139

1.49

1.30

1.1

20.05

25.55

u/l

1.02

Headache

160

1.51

1.30

1.1

23.23

21.01

u/l

0.28

103

Other disorders of urethra and urinary system

211

1.42

1.29

1.2

1.1

21.42

19.95

u/l

0.14

144

Dental operations

182

1.38

1.27

1.1

16.71

20.19

u/l

0.83

116

Intracranial injury

235

1.44

1.26

1.2

1.1

17.76

19.64

u/l

0.34

157

Seropositive rheumatoid arthritis

1.71

1.26

1.0

1.1

19.05

20.34

u/l

0.11

Dental pulpitis 2

178

1.38

1.24

1.1

18.64

19.25

u/l

0.09

117

Benign paroxysmal vertigo

118

0.42

1.24

1.6

1.2

29.20

20.27

u/l

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

123

1.63

1.23

1.2

1.1

28.91

19.22

u/l

0.61

Dental caries 1, only avohilmo

209

1.35

1.22

1.1

17.44

19.95

u/l

0.47

139

Other disorders of white blood cells

2.64

1.21

1.0

1.3

22.54

26.86

u/l

—

Thyroiditis

2.63

1.21

1.2

1.1

26.64

26.72

u/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1.80

1.20

1.1

1.2

18.91

25.56

u/l

—

Non-selective monoamine reuptake inhibitors

159

1.53

1.19

1.0

1.1

22.24

19.51

u/l

0.26

105

Ischaemic Stroke, excluding all haemorrhages

223

1.39

1.19

1.1

21.87

18.96

u/l

0.43

158

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

101

1.68

1.19

1.0

1.2

19.05

22.08

u/l

0.31

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

153

1.49

1.19

1.1

21.99

21.90

u/l

0.01

104

Pain in joint

156

1.44

1.18

1.1

21.23

20.52

u/l

0.10

103

Poisoning by medicine

1.88

1.17

1.0

1.1

19.96

26.64

u/l

—

Pure hypercholesterolaemia

204

1.38

1.16

1.1

18.41

19.49

u/l

0.21

129

Other/unspecified seropositive rheumatoid arthritis

102

1.67

1.16

1.0

1.2

19.05

21.92

u/l

0.29

Anxiety (asthma-related co-morbidities)

149

1.48

1.15

1.1

27.62

23.40

u/l

0.31

Viral infections characterized by skin and mucous membrane lesions

158

1.52

1.13

1.0

1.2

23.67

20.75

u/l

0.21

108

DVT of lower extremities

1.75

1.12

1.1

1.2

32.05

19.06

u/l

—

Coxarthrosis [arthrosis of hip](FG)

167

1.43

1.12

1.2

1.1

17.55

19.34

u/l

0.29

113

Seropositive rheumatoid arthritis, wide

103

1.65

1.12

1.0

1.2

19.05

21.92

u/l

0.29

Persons encountering health services for examination and investigation

148

1.39

1.12

1.2

1.1

21.20

19.56

u/l

0.14

100

Dental pulpitis 2, only avohilmo

182

1.35

1.11

1.1

18.52

19.06

u/l

0.08

119

Benign neoplasm of major salivary glands

2.26

1.10

1.4

1.2

20.26

24.65

u/l

—

Heartburn

2.26

1.10

1.1

19.14

21.42

u/l

—

Soft tissue disorders

244

1.30

1.10

1.2

1.1

21.82

20.23

u/l

0.18

154

Basal cell carcinoma, including avohilmo

230

1.37

1.09

1.2

1.1

19.91

18.72

u/l

0.11

150

Open wound of head

231

1.41

1.08

1.1

25.27

19.30

u/l

0.57

152

Other diseases of oesophagus

2.19

1.08

1.1

1.3

20.63

20.54

u/l

—

Alcohol use disorder, ICD-based

185

1.46

1.08

1.1

21.38

20.10

u/l

0.15

120

Basal cell carcinoma

227

1.37

1.07

1.2

1.1

19.91

18.77

u/l

0.11

147

Degenerative macular diseases

1.87

1.07

1.2

16.95

21.78

u/l

—

Injuries to the thorax

202

1.44

1.06

1.1

21.32

19.03

u/l

0.26

133

Dislocation, sprain and strain of joints and ligaments of knee

214

0.61

1.06

1.1

17.14

22.22

u/l

—

144

Poisoning by drugs, medicaments and biological substances

1.76

1.06

1.0

1.1

18.00

25.61

u/l

—

Cutaneous abscess, furuncle and carbuncle

1.65

1.06

1.1

18.81

20.74

u/l

—

Other acute lower respiratory infections

225

1.40

1.06

1.2

1.1

19.13

20.19

u/l

0.16

148

Paralytic ileus and intestinal obstruction

113

1.59

1.05

1.0

1.2

25.48

17.58

u/l

0.57

Other benign neoplasms of skin

119

1.57

1.04

1.2

1.1

16.79

18.28

u/l

0.16

Sulfasalazine

1.67

1.03

1.0

1.1

19.80

21.84

u/l

—

Suicide or other Intentional self-harm

1.73

1.02

1.2

1.1

18.90

25.02

u/l

—

Asthma-related infections

243

1.38

1.00

1.1

19.00

20.14

u/l

0.19

161

Asthma, hospital admission 2, infections

243

1.38

1.00

1.1

19.00

20.14

u/l

0.19

161

Coxibs

1.50

1.00

1.3

1.2

16.25

20.53

u/l

0.59

Constipation

281

1.30

1.00

1.2

1.1

19.58

20.20

u/l

0.09

180

Coxarthrosis

149

1.41

1.00

1.2

1.1

17.83

18.33

u/l

0.07

Dental caries 3, only avohilmo

222

1.29

0.98

1.1

18.14

20.30

u/l

0.38

148

Faecal incontinence

2.18

0.98

1.2

1.1

27.40

23.89

u/l

—

conjunctival haemorrhage

0.00

0.97

0.0

1.2

—

21.58

—

Sequelae of injuries of upper limb

0.00

0.97

0.0

1.2

—

24.43

—

Fracture of rib(s), sternum and thoracic spine

140

1.50

0.97

1.1

1.2

23.00

18.28

u/l

0.47

Intestinal stricture

149

1.48

0.95

1.0

1.1

24.42

18.60

u/l

0.57

103

Dental pulpitis 1, only avohilmo

270

1.26

0.95

1.1

20.05

20.61

u/l

0.08

182

Dental pulpitis 4, only avohilmo

270

1.26

0.95

1.1

20.05

20.61

u/l

0.08

182

Diseases of male genital organs

133

1.37

0.94

1.3

1.0

20.01

18.39

u/l

0.30

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1.65

0.94

1.1

18.91

27.58

u/l

—

Persons with potential health hazards related to communicable diseases

108

1.56

0.93

1.1

20.78

24.52

u/l

—

Unspecific neurodegenerative disorder

162

0.64

0.93

1.1

1.2

15.63

17.22

u/l

—

111

Injuries to the head

305

1.26

0.92

1.1

20.42

20.41

u/l

0.00

200

Other noninflammatory disorders of uterus, except cervix

1.79

0.90

1.2

1.0

18.31

21.99

u/l

0.31

Other neurological diseases

272

1.30

0.90

1.2

1.1

19.28

19.74

u/l

0.06

184

Dorsalgia

249

1.26

0.89

1.1

23.09

20.13

u/l

0.35

164

Other nutritional deficiencies

214

1.37

0.88

1.1

21.16

22.72

u/l

0.17

140

Diaphragmatic hernia

160

1.44

0.88

1.0

1.1

22.18

20.39

u/l

0.20

112

Other malignant neoplasms of skin (=non-melanoma skin cancer)

220

1.33

0.88

1.2

1.1

20.87

18.57

u/l

0.23

142

Diseases of inner ear

247

0.67

0.86

1.2

1.1

25.13

19.08

u/l

0.66

167

Open wound of forearm

1.94

0.84

1.3

1.2

10.72

24.91

u/l

—

Myocardial infarction, without ST-elevation

196

1.37

0.84

1.2

1.1

14.66

18.41

u/l

1.19

127

Sulfonylureas

142

1.41

0.83

1.2

1.1

12.05

18.72

u/l

2.01

101

Cystitis

225

1.28

0.82

1.1

21.39

19.91

u/l

0.22

152

Diverticular disease of intestine

211

1.29

0.80

1.2

1.1

17.32

18.60

u/l

0.20

131

Alzheimer’s disease (Early onset), excluding more controls

0.00

0.79

0.0

1.2

—

17.05

—

Lesion of plantar nerve

0.00

0.79

0.0

1.1

—

22.64

—

Nontoxic single thyroid nodule

0.00

0.79

0.0

1.2

—

27.17

—

Fracture of neck

0.00

0.78

0.0

1.2

—

22.50

—

Synovial cyst of popliteal space [Baker]

0.00

0.78

0.0

1.0

—

20.65

—

Spontaneous rupture of synovium and tendon

0.00

0.78

0.0

1.0

—

22.12

—

Other problems related to primary support group, including family circumstances

0.00

0.78

0.0

1.1

—

23.32

—

Artrosis, including avohilmo

223

1.25

0.78

1.2

1.1

22.07

20.69

u/l

0.18

144

Unspecified lump in breast

1.77

0.76

1.0

1.1

23.50

28.59

u/l

—

Acute sinusitis

178

1.36

0.76

1.2

1.1

15.54

22.23

u/l

1.80

117

Disorders of eyelid, lacrimal system and orbit

294

1.25

0.76

1.2

1.1

25.38

19.53

u/l

0.75

192

Exposure to unspecified factor

312

1.24

0.75

1.1

22.01

20.40

u/l

0.20

208

Alzheimer disease, including avohilmo

143

0.66

0.75

1.1

1.2

17.57

17.14

u/l

—

Dental operations, only avohilmo

200

1.26

0.75

1.1

17.33

21.17

u/l

0.80

130

Other symptoms and signs involving cognitive functions and awareness

196

1.34

0.74

1.1

19.06

19.34

u/l

0.03

137

Other dorsopathies, not elsewhere classified

249

1.23

0.74

1.2

1.1

23.46

20.13

u/l

0.40

164

Chronic diseases of tonsils and adenoids

199

0.73

0.74

1.1

30.36

21.91

u/l

0.74

135

Type 1 diabetes, strict (exclude DM2)

2.00

0.72

1.0

36.40

23.19

u/l

—

Type 1 diabetes, definitions combined

2.00

0.72

1.0

36.40

20.20

u/l

—

Strabismus

1.52

0.71

1.1

1.2

16.31

22.37

u/l

—

Other blood glucose lowering drugs, excl. Insulins

1.62

0.71

1.2

1.1

12.17

18.77

u/l

—

Gonarthrosis [arthrosis of knee](FG)

190

1.27

0.71

1.0

1.1

16.22

20.30

u/l

0.96

130

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

263

1.29

0.71

1.1

20.98

19.85

u/l

0.13

169

Alzheimer disease

129

0.64

0.70

1.1

1.2

15.40

17.52

u/l

—

Tooth eruption problems

1.90

0.70

1.2

1.0

25.20

23.43

u/l

—

Alcohol dependence

126

1.43

0.70

1.1

1.2

21.92

19.53

u/l

0.26

Symptoms and signs involving the skin and subcutaneous tissue

281

1.27

0.70

1.1

16.68

21.11

u/l

0.76

187

Artificial joint operation, meniscal resection

304

0.79

0.70

1.0

1.1

16.76

19.76

u/l

0.65

200

Disorders of conjunctiva

267

0.75

0.67

1.1

28.36

20.96

u/l

0.62

183

Gonarthrosis, primary, with knee surgery

223

0.73

0.67

1.0

1.1

15.49

19.78

u/l

0.77

150

Other and unspecified glaucoma

1.79

0.66

1.2

11.00

23.68

u/l

—

Obesity

212

1.31

0.66

1.1

19.02

23.00

u/l

0.73

139

Cholelithiasis, broad definition with cholecystitis

268

1.23

0.66

1.1

17.52

20.55

u/l

0.61

174

Phlebitis and thrombophlebitis (not including DVT)

1.51

0.66

1.2

16.61

20.10

u/l

—

Gonarthrosis

162

1.27

0.65

1.1

16.00

19.72

u/l

0.90

107

Asthma (diagnoses ohter than nonallergic)

305

1.23

0.65

1.1

19.32

20.68

u/l

0.25

206

Cholecystectomy

268

1.25

0.65

1.2

1.1

19.35

20.09

u/l

0.09

185

Obesity and other hyperalimentation

213

1.30

0.64

1.1

19.02

23.12

u/l

0.76

140

Acute upper respiratory infections

292

1.20

0.62

1.2

1.1

20.76

20.27

u/l

0.06

193

Disorders of ocular muscles, binocular movement, accommodation and refraction

172

1.33

0.60

1.2

1.1

17.45

22.43

u/l

1.03

114

Perineal laceration during delivery

0.00

0.60

0.0

1.0

—

32.21

—

Malignant neoplasm of stomach

0.00

0.60

0.0

1.3

—

27.69

—

Other infective otitis externa

0.00

0.60

0.0

1.1

—

23.29

—

Speech and linguistic disorders

0.00

0.60

0.0

1.1

—

24.66

—

Alzheimer’s disease (Early onset)

0.00

0.60

0.0

1.3

—

26.25

—

Glaucoma-related operations

0.00

0.60

0.0

1.2

—

26.52

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

0.60

0.0

1.0

—

23.93

—

Corns and callosities

0.00

0.60

0.0

1.2

—

25.00

—

Postprocedural disorders of nervous system

0.00

0.60

0.0

1.0

—

26.94

—

Eating disorders

0.00

0.60

0.0

1.1

—

26.52

—

Injuries to the hip and thigh

208

1.28

0.58

1.2

1.1

20.65

18.34

u/l

0.24

140

Benign neoplasm of other and ill-defined parts of digestive system

1.56

0.58

1.2

16.62

23.77

u/l

—

Use of selegiline

0.00

0.58

0.0

1.2

—

24.50

—

Chronic suppurative otitis media, including avohilmo

0.00

0.58

0.0

1.2

—

26.62

—

Embedded and impacted teeth

1.48

0.57

1.1

1.0

18.79

25.54

u/l

—

Disorders of the thyroid gland

273

1.20

0.56

1.1

18.22

21.40

u/l

0.82

173

Inflammatory diseases of female pelvic organs

113

1.33

0.54

1.0

1.1

23.60

24.93

u/l

0.07

Nontraumatic intracranial haemmorrhage

1.41

0.54

1.1

16.96

18.83

u/l

—

Tonsillectomy and adenotomy

119

0.70

0.53

1.1

32.57

23.66

u/l

—

Other retinal disorders

252

1.21

0.50

1.1

17.43

19.95

u/l

0.26

167

Obesity, other/unspecified

109

1.38

0.50

1.1

19.14

22.73

u/l

—

Obesity due to excess calories

171

1.29

0.49

1.1

18.53

22.97

u/l

0.65

112

Dorsopathies

249

1.17

0.49

1.2

1.1

21.29

20.13

u/l

0.12

164

Diseases of the eye and adnexa

175

1.20

0.49

1.1

23.19

20.73

u/l

0.22

120

Shoulder lesions

226

0.81

0.49

1.2

1.1

18.14

20.23

u/l

0.34

142

Cholelithiasis

266

1.19

0.48

1.2

1.1

17.80

20.58

u/l

0.51

173

Sequelae of cerebrovascular disease

166

1.27

0.48

1.1

21.86

18.08

u/l

0.62

116

Lower back pain or/and sciatica

323

0.84

0.48

1.1

26.09

19.98

u/l

0.53

218

Dizziness and giddiness

264

1.20

0.48

1.1

20.67

20.17

u/l

0.07

173

Degenerative diseases of the nervous system

142

0.74

0.46

1.1

1.2

17.00

17.04

u/l

—

Procreative management

1.37

0.46

1.0

25.67

27.32

u/l

—

Injury, poisoning and certain other consequences of external causes

126

1.23

0.46

1.2

1.1

24.90

21.44

u/l

0.27

Spondylopathies

237

1.18

0.46

1.2

1.1

22.98

19.94

u/l

0.31

156

Examination and observation for other reasons

143

1.23

0.45

1.1

24.07

19.72

u/l

0.63

Dementia

160

0.78

0.44

1.0

1.2

13.50

17.83

u/l

—

115

Fibroblastic disorders

121

1.32

0.44

1.3

1.1

18.36

19.11

u/l

0.11

Depression or dysthymia

189

1.18

0.42

1.1

21.59

20.28

u/l

0.14

124

Single spontaneous delivery

1.33

0.42

1.1

33.88

22.52

u/l

—

malignant neoplasm of male genital organs

167

0.80

0.41

1.3

1.1

17.91

16.74

u/l

0.14

107

Diabetic retinopathy

124

0.76

0.41

1.0

1.2

20.94

18.94

u/l

—

Disorders of lacrimal system

167

1.26

0.41

1.2

1.1

26.46

19.70

u/l

0.47

112

Speech and linguistic disorders, excluding more controls

0.00

0.41

0.0

1.3

—

21.73

—

Disorders of speech understanding and production

0.00

0.41

0.0

1.1

—

28.63

—

Hypersensitivity pneumonitis due to organic dust

0.00

0.41

0.0

1.1

—

28.63

—

Respiratory conditions due to other external agents

0.00

0.41

0.0

1.1

—

27.23

—

Other conjunctival vascular disorders and cysts

0.00

0.41

0.0

1.1

—

28.63

—

Post-traumatic wound infection, not elsewhere classified

0.00

0.41

0.0

1.1

—

28.63

—

Benign neoplasm: Anus and anal canal

0.00

0.41

0.0

1.1

—

28.63

—

Other encephalitis

0.00

0.41

0.0

1.1

—

28.63

—

Adenocarcinoma and papillary adenocarcinoma of stomach

0.00

0.41

0.0

1.2

—

27.23

—

Occupational exposure to risk-factors

0.00

0.41

0.0

1.3

—

29.73

—

Other specified disorders of kidney and ureter

0.00

0.41

0.0

1.1

—

28.63

—

Pedal cyclist injured in collision with motor vehicle

0.00

0.41

0.0

1.1

—

28.63

—

Dementia due to Parkinson's disease

0.00

0.41

0.0

1.3

—

27.33

—

Carcinoma in situ of skin of trunk

0.00

0.41

0.0

1.3

—

27.66

—

Other, unspecified and serous retinal detachments

0.00

0.41

0.0

1.3

—

29.30

—

Use of levodopa decarbox-comt-inhibitor

0.00

0.41

0.0

1.3

—

27.66

—

Benign neoplasm: Larynx

0.00

0.41

0.0

1.1

—

28.63

—

Glaucoma secondary to other eye disorders

0.00

0.41

0.0

1.1

—

29.63

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.00

0.41

0.0

1.1

—

28.57

—

Atopic dermatitis

150

1.25

0.41

1.0

1.1

24.56

24.46

u/l

0.01

Neuralgia and neuritis, unspecified

0.00

0.41

0.0

1.0

—

19.64

—

Oesophagitis

0.00

0.41

0.0

1.1

—

28.21

—

Other congenital malformations of the digestive system

0.00

0.41

0.0

1.1

—

28.57

—

LSIL lesion of the cervix uteri

0.00

0.41

0.0

1.1

—

32.36

—

133

0.73

0.41

1.2

11.72

17.99

u/l

—

Biomechanical lesions, not elsewhere classified

0.00

0.40

0.0

1.2

—

27.69

—

Oral lichen ruber planus, including avohilmo

0.00

0.40

0.0

1.1

—

28.13

—

Polycystic ovarian syndrome, consortium definition

111

1.25

0.40

1.1

24.09

25.42

u/l

0.11

Correction of physiology of bite - demanding therapy visit

0.00

0.40

0.0

1.1

—

26.86

—

Postpartum haemorrhage due to retained placenta

0.00

0.40

0.0

1.1

—

39.42

—

Delivery

1.32

0.40

1.1

33.88

22.52

u/l

—

Acute bronchiolitis

0.00

0.40

0.0

1.1

—

28.63

—

Spondylosis

214

1.20

0.40

1.2

1.1

28.98

19.48

u/l

0.87

143

Progressive vascular leukoencephalopathy

0.00

0.40

0.0

1.2

—

23.08

—

Neovascular glaucoma

0.00

0.40

0.0

1.2

—

26.52

—

Examination and encounter for administrative purposes

0.00

0.40

0.0

1.1

—

17.44

—

Specific development disorders of speech and language

0.00

0.39

0.0

1.1

—

26.52

—

Infective dermatitis

1.43

0.39

1.2

1.1

20.60

25.35

u/l

—

Other benign neoplasms of uterus

0.00

0.39

0.0

1.1

—

31.04

—

Oral leukoplakia and related diseases

0.00

0.39

0.0

1.1

—

24.50

—

Use of biperiden

0.00

0.39

0.0

1.1

—

27.07

—

Calcific tendinitis of shoulder

0.00

0.39

0.0

1.0

—

19.54

—

Contact with other sharp object(s)

0.00

0.39

0.0

1.1

—

26.21

—

Chronic suppurative otitis media

0.00

0.39

0.0

1.2

—

27.19

—

Transient ischemic attack

223

1.19

0.38

1.2

1.1

20.20

18.86

u/l

0.16

155

Other diseases of hard tissues of teeth

173

1.21

0.38

1.0

1.1

16.18

21.85

u/l

0.82

113

Speech disturbances, not elsewhere classified

1.39

0.38

1.4

1.2

16.00

22.46

u/l

—

Malignant neoplasm of rectum

1.39

0.38

1.0

1.2

18.80

21.04

u/l

—

Glaucoma

245

0.82

0.37

1.3

1.1

14.61

19.25

u/l

1.27

164

Disorders of choroid and retina

285

1.15

0.36

1.1

18.13

20.08

u/l

0.22

186

Spinal stenosis

205

1.19

0.36

1.2

1.1

22.57

18.28

u/l

0.37

137

Follow-up examination after treatment for conditions other than malignant neoplasms

117

1.23

0.36

1.1

26.40

19.59

u/l

0.94

Varicose veins

219

1.17

0.35

1.1

17.52

19.47

u/l

0.39

151

Unspecified fall

215

1.20

0.35

1.2

1.1

20.21

19.73

u/l

0.08

142

Noninfective enteritis and colitis

189

1.22

0.35

1.1

27.98

20.24

u/l

0.41

122

Diseases of middle ear and mastoid

170

1.20

0.35

1.1

27.60

21.32

u/l

0.60

115

Other intervertebral disc disorders

242

0.86

0.34

1.1

21.74

20.27

u/l

0.18

159

Injuries to the ankle and foot

225

1.17

0.32

1.2

1.1

19.74

22.28

u/l

0.37

148

Psoriasis vulgaris

1.35

0.32

1.3

1.1

17.90

19.98

u/l

—

Carpal tunnel syndrome

228

0.83

0.32

1.0

1.1

21.88

20.71

u/l

0.07

153

Benign neoplasm: Colon, unspecified

119

1.26

0.31

1.1

1.2

12.98

19.63

u/l

—

Any dementia

147

0.81

0.31

1.0

1.2

14.40

17.16

u/l

—

101

Persons encountering health services in circumstances related to reproduction

134

0.81

0.30

1.0

1.1

28.22

23.50

u/l

—

Injuries to the elbow and forearm

243

1.15

0.28

1.1

20.34

20.93

u/l

0.05

163

Sub-endpoint used in defining T1D endpoints

137

1.22

0.28

1.0

1.2

20.95

20.12

u/l

0.03

Asthma, including avohilmo

310

1.11

0.28

1.1

19.82

20.60

u/l

0.15

211

Malignant neoplasm of prostate

164

0.85

0.28

1.3

1.1

17.52

16.68

u/l

0.10

105

Hypothyroidism, strict autoimmune

197

1.14

0.27

1.1

16.61

21.34

u/l

1.38

121

Haemorrhoids and perianal venous thrombosis

131

1.22

0.27

1.1

21.73

17.57

u/l

0.44

Transport accidents

157

1.19

0.27

1.1

19.80

21.58

u/l

0.15

104

Acute bronchitis

183

1.18

0.26

1.1

19.41

19.01

u/l

0.04

120

Conjunctivitis

243

0.86

0.26

1.1

28.36

21.60

u/l

0.55

168

Disturbances of skin sensation

1.26

0.26

1.1

12.20

24.88

u/l

—

Other cataract

152

1.17

0.26

1.3

1.1

20.77

19.13

u/l

0.26

100

Other benign neoplasms of skin

160

1.19

0.25

1.2

16.79

20.29

u/l

0.43

111

Fenamates

0.74

0.24

1.0

1.2

19.77

22.01

u/l

—

Coxarthrosis, primary

255

1.12

0.23

1.2

1.1

16.38

19.55

u/l

0.69

170

Other disorders of eyelid

214

0.86

0.22

1.1

20.07

19.22

u/l

0.05

145

Selective serotonin reuptake inhibitors

255

1.09

0.22

1.1

23.83

19.76

u/l

0.78

165

Gonarthrosis,primary

275

1.10

0.22

1.0

1.1

16.88

20.07

u/l

0.84

183

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

1.19

0.21

1.0

1.2

18.80

14.48

u/l

—

Urethritis and urethral syndrome

0.00

0.21

0.0

1.1

—

34.72

—

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.3

—

16.06

—

Benign neoplasm: Anus and anal canal

0.00

0.21

0.0

1.3

—

13.86

—

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.3

—

16.06

—

Benign neoplasm: Larynx

0.00

0.21

0.0

1.3

—

13.86

—

Lumbosacral root disorders, not elsewhere classified

0.00

0.21

0.0

1.1

—

18.61

—

Oral leukoplakia

0.00

0.21

0.0

1.1

—

32.19

—

Oral leukoplakia, including avohilmo

0.00

0.21

0.0

1.1

—

32.19

—

Chondromalacia

0.00

0.21

0.0

1.1

—

34.76

—

Correction of physiology of bite - very demanding therapy visit

0.00

0.21

0.0

1.1

—

32.61

—

Oesophageal obstruction

0.00

0.21

0.0

1.2

—

37.60

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

0.21

0.0

1.0

—

43.00

—

Contusion of other and unspecified parts of foot

0.00

0.21

0.0

1.1

—

30.90

—

Hypothyroidism, other/unspecified

258

1.10

0.21

1.1

16.96

21.40

u/l

1.47

167

Toxic effect of alcohol

0.00

0.21

0.0

1.1

—

19.79

—

Complications of genitourinary prosthetic devices, implants and grafts

0.00

0.21

0.0

1.1

—

32.41

—

Lactose intolerance, other/unspecified

0.00

0.21

0.0

1.1

—

19.41

—

Other and unspecified erythematous conditions

0.00

0.21

0.0

1.1

—

33.54

—

Meralgia paraesthetica

0.00

0.21

0.0

1.1

—

19.54

—

Anorexia (incl.atypical)

0.00

0.21

0.0

1.1

—

33.79

—

Eating disorder

0.00

0.21

0.0

1.1

—

30.16

—

Personal history of other diseases and conditions

0.00

0.21

0.0

1.1

—

33.00

—

Depression

263

1.10

0.20

1.0

1.1

23.36

21.33

u/l

0.24

173

conjunctival degenerations and deposits

0.00

0.20

0.0

1.1

—

28.70

—

Chronic Coagulation defects

0.00

0.20

0.0

1.1

—

29.03

—

Secondary parkinsonism

0.00

0.20

0.0

1.1

—

28.70

—

Benign neoplasm: other/unspecified salivary gland

0.00

0.20

0.0

1.1

—

28.70

—

Secondary parkinsonism+Parkinsonism in other disease

0.00

0.20

0.0

1.1

—

28.70

—

Chorioretinal inflammation

0.00

0.20

0.0

1.1

—

30.70

—

Other specified/unspecified disorders of bone/cartilage

0.00

0.20

0.0

1.1

—

27.78

—

Vascular dementia (subcortical)

0.00

0.20

0.0

1.4

—

29.26

—

Other and unspecified mononeuropathies, also in other diseases

0.00

0.20

0.0

1.1

—

18.48

—

Congenital iodine-deficiency syndrome/hypothyroidism

0.00

0.20

0.0

1.1

—

31.92

—

Disorder of external ear, unspecified

0.00

0.20

0.0

1.1

—

29.03

—

Lactose intolerance

0.00

0.20

0.0

1.1

—

17.70

—

Other erythematous conditions

0.00

0.20

0.0

1.1

—

30.26

—

Viral meningitis

0.00

0.20

0.0

1.1

—

26.70

—

Other specified and unspecified disorders of eye and adnexa

0.00

0.20

0.0

1.1

—

30.70

—

Other and unspecified injuries of ankle and foot

0.00

0.20

0.0

1.1

—

27.70

—

Atopic conjunctivitis

0.00

0.20

0.0

1.1

—

30.26

—

Prolapse and hernia of ovary and fallopian tube

0.00

0.20

0.0

1.1

—

22.85

—

Oxicams

1.18

0.20

1.1

1.2

18.25

20.49

u/l

—

Dermatitis

240

1.12

0.20

1.1

19.21

21.42

u/l

0.32

157

Hernia of abdominal wall

193

1.14

0.19

1.1

15.75

20.65

u/l

0.81

131

Umbilical hernia

109

1.19

0.18

1.1

11.21

20.26

u/l

—

Allergic rhinitis

1.21

0.17

1.3

1.1

22.67

26.67

u/l

—

Fracture of lower leg, including ankle

232

1.12

0.17

1.2

1.1

19.73

21.33

u/l

0.16

155

Alzheimer’s disease, wide definition

110

0.84

0.17

1.1

1.2

17.40

17.13

u/l

—

Vasomotor and allergic rhinitis

127

1.16

0.17

1.2

1.1

20.63

22.81

u/l

—

Palmar fascial fibromatosis [Dupuytren]

1.20

0.16

1.1

18.67

18.48

u/l

—

Sensorineural hearing loss

266

1.08

0.15

1.2

1.1

13.22

19.29

u/l

2.34

180

Any dementia, excluding more controls

133

0.89

0.14

1.0

1.2

14.40

16.28

u/l

—

Osteopathies and chondropathies

225

1.10

0.13

1.1

23.39

19.70

u/l

0.50

146

Coxarthrosis, primary, with hip surgery

225

1.10

0.13

1.2

1.1

14.66

19.50

u/l

1.23

153

Other and unspecified dermatitis

199

1.11

0.13

1.1

20.33

21.56

u/l

0.13

131

Use of memantine

120

0.87

0.12

1.1

1.2

15.17

17.54

u/l

—

Use of other anti-dementia drugs

120

0.87

0.12

1.1

1.2

15.17

17.54

u/l

—

Injuries to the shoulder and upper arm

315

0.93

0.12

1.0

1.1

24.50

19.73

u/l

0.73

203

Dental caries 2, only avohilmo

215

0.92

0.12

1.1

17.50

23.30

u/l

1.21

144

Lumbar disc prolapse

224

0.92

0.11

1.1

20.89

20.23

u/l

0.06

149

Disorders of sclera, cornea, iris and ciliary body

219

0.91

0.11

1.2

1.1

22.57

20.86

u/l

0.10

141

Dental caries 2 and operation codes, only avohilmo

155

0.92

0.10

1.1

16.97

21.59

u/l

0.77

106

Acetic acid derivatives and related substances

1.10

0.09

1.5

1.2

19.44

20.53

u/l

0.07

Other headache syndromes

145

0.90

0.09

1.0

1.1

27.88

21.42

u/l

—

103

Gestational [pregnancy-induced] hypertension

1.04

0.09

1.4

1.1

22.80

30.41

u/l

—

Diseases of the ear and mastoid process

281

1.04

0.09

1.1

23.28

19.91

u/l

0.55

189

Other diseases of upper respiratory tract

294

0.96

0.08

1.1

23.71

19.88

u/l

0.71

195

Hypothyreosis and Thyroxine purchase for inclusion criteria

270

1.05

0.08

1.1

16.96

21.25

u/l

1.43

176

Other symptoms and signs involving the nervous and musculoskeletal systems

175

1.09

0.08

1.1

18.63

21.17

u/l

0.28

116

Conductive and sensorineural hearing loss

270

1.05

0.08

1.2

1.1

13.22

19.10

u/l

2.25

183

Asthma/COPD (KELA code 203)

275

1.05

0.08

1.0

1.1

18.89

21.29

u/l

0.46

185

174

1.08

0.08

1.2

1.1

20.30

21.63

u/l

—

118

Acute upper respiratory infections of multiple and unspecified sites

227

1.06

0.07

1.1

25.05

21.26

u/l

0.45

151

Abnormal serum enzyme levels

145

1.09

0.07

1.2

1.1

22.50

18.80

u/l

—

Asthma, hospital admissions , main diagnosis only

307

1.05

0.07

1.1

19.17

20.83

u/l

0.26

207

Mood disorders

288

0.96

0.07

1.0

1.1

22.58

20.67

u/l

0.23

190

Alzheimer’s disease (Late onset), excluding more controls

1.13

0.07

1.1

1.2

17.40

15.66

u/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

0.84

0.06

1.0

1.1

25.75

23.01

u/l

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

254

0.94

0.06

1.1

21.61

19.63

u/l

0.19

168

Ventral hernia

105

0.86

0.06

1.2

1.1

15.11

20.41

u/l

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

173

1.06

0.06

1.1

24.32

23.36

u/l

0.08

118

Triptan medication for migraine, single purchase ok

173

1.06

0.06

1.1

24.32

23.36

u/l

0.08

118

Alzheimer’s disease (Late onset)

104

0.91

0.06

1.1

1.2

17.40

17.45

u/l

—

Injuries to the knee and lower leg

308

0.97

0.06

1.1

20.03

20.77

u/l

0.09

207

Fracture of forearm

194

1.06

0.06

1.0

1.1

22.42

19.69

u/l

0.16

128

Mood [affective] disorders

287

0.96

0.06

1.0

1.1

22.58

20.67

u/l

0.23

189

Organic, including symptomatic, mental disorders

192

1.05

0.05

1.0

1.2

12.22

18.12

u/l

2.32

134

Disorders of skin appendages

178

1.07

0.05

1.2

1.1

23.36

22.11

u/l

0.07

121

Allergic conjunctivitis

178

0.94

0.04

1.1

27.89

22.62

u/l

—

125

Visual disturbances and blindness

219

1.05

0.04

1.1

18.35

19.87

u/l

0.26

145

Propionic acid derivatives

1.06

0.04

1.3

1.2

18.25

20.53

u/l

0.26

Anti-inflammatory and antirheumatic products, non-steroids

1.06

0.04

1.3

1.2

17.28

20.53

u/l

0.37

Inguinal hernia

201

1.04

0.04

1.2

1.1

13.63

20.19

u/l

2.25

132

Symptoms and signs involving the nervous and musculoskeletal systems

250

1.04

0.03

1.2

1.1

18.18

20.38

u/l

0.33

165

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

216

1.04

0.03

1.2

1.1

22.67

21.19

u/l

0.14

146

Degeneration of macula and posterior pole

207

1.04

0.02

1.1

15.42

19.00

u/l

0.82

138

Acute alcohol intoxication

117

0.94

0.01

1.0

1.2

13.63

18.99

u/l

—

Nerve, nerve root and plexus disorders

309

1.02

0.01

1.1

22.10

20.11

u/l

0.17

205

Obesity related asthma

134

1.04

0.00

1.1

21.33

20.90

u/l

—

Fall on same level involving ice and snow

233

0.99

0.00

1.3

1.1

19.63

20.81

u/l

0.16

154

Dental caries 2

216

1.02

0.00

1.1

18.30

23.16

u/l

1.00

145

Exposure to other specified factors

273

1.00

0.00

1.1

24.77

20.64

u/l

0.50

182

Chronic sinusitis

177

1.02

0.00

1.3

1.1

21.25

20.98

u/l

0.02

119

Low back pain

242

0.99

0.00

1.1

27.45

20.12

u/l

0.45

160

Dementia, including avohilmo

167

0.99

0.00

1.0

1.2

16.10

17.56

u/l

0.23

118

Other disorders of ear

290

1.01

0.00

1.2

1.1

18.72

20.09

u/l

0.16

194

Gastro-oesophageal reflux disease

240

1.00

0.00

1.1

17.08

19.96

u/l

0.68

145

Mood disorders, excluding more controls

246

1.01

0.00

1.0

1.1

22.04

20.31

u/l

0.20

161

Hypothyroidism, strict autoimmune, 3 medication purchases required

256

0.99

0.00

1.1

16.23

21.08

u/l

1.60

166

Meniscus derangement

164

1.00

0.00

1.0

1.1

32.09

19.91

u/l

0.68

106

Mouth breathing

168

1.01

0.00

1.1

20.75

21.32

u/l

0.06

108

Visual disturbances

197

1.02

0.00

1.2

1.1

18.86

20.70

u/l

0.26

127

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

172

0.97

0.00

1.1

27.89

22.05

u/l

—

121

Dental caries 2 and operation codes

212

1.01

0.00

1.1

17.98

23.24

u/l

1.07

141

Injuries to the wrist and hand

308

0.99

0.00

1.1

18.52

21.15

u/l

0.50

202

Retinal detachments and breaks

171

0.99

0.00

1.1

23.80

20.17

u/l

0.16

119

Other disorders of bladder

0.89

0.00

1.2

22.60

18.37

u/l

—

Dislocation of lens

0.00

0.0

1.4

—

Polymyalgia rheumatica

0.86

0.00

1.0

1.2

21.80

22.14

u/l

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS